Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 315 articles:
HTML format



Single Articles


    June 2022
  1. HIRAHARA N, Matsubara T, Kaji S, Hayashi H, et al
    Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.
    BMC Cancer. 2022;22:718.
    PubMed     Abstract available


  2. ZHU J, Fang R, Pan Z, Qian X, et al
    Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:716.
    PubMed     Abstract available


  3. LI J, Tang LL, Ma J
    Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    BMC Cancer. 2022;22:714.
    PubMed     Abstract available


  4. ZHOU M, Yang W, Xuan Y, Zou W, et al
    A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRac
    BMC Cancer. 2022;22:710.
    PubMed     Abstract available


  5. ALMADORI G, Coli A, De Corso E, Mele DA, et al
    Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.
    BMC Cancer. 2022;22:704.
    PubMed     Abstract available


  6. LIN Z, Rao W, Xiang Z, Zeng Q, et al
    Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:696.
    PubMed     Abstract available


  7. DEGUCHI S, Tanaka H, Suzuki S, Natsuki S, et al
    Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:699.
    PubMed     Abstract available


  8. SHAVER AL, Platek ME, Singh AK, Ma SJ, et al
    Effect of musculature on mortality, a retrospective cohort study.
    BMC Cancer. 2022;22:688.
    PubMed     Abstract available


  9. ZHOU G, Zhang S, Jin M, Hu S, et al
    Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
    BMC Cancer. 2022;22:667.
    PubMed     Abstract available


  10. SHI J, Wang L, Yao N, Sun L, et al
    The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis.
    BMC Cancer. 2022;22:658.
    PubMed     Abstract available


  11. CAO Y, Han D, Yang S, Shi Y, et al
    Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
    BMC Cancer. 2022;22:650.
    PubMed     Abstract available


  12. TSAI PC, Chien HC, Hsu PK, Hung JJ, et al
    Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy.
    BMC Cancer. 2022;22:637.
    PubMed     Abstract available


  13. MAAHS L, Ghanem AI, Gutta R, Tang A, et al
    Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy.
    BMC Cancer. 2022;22:626.
    PubMed     Abstract available


  14. LI Z, Li C, Yang D, Song J, et al
    Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2022;22:616.
    PubMed     Abstract available


  15. LO WC, Chang CM, Wu CY, Hsieh CH, et al
    A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation.
    BMC Cancer. 2022;22:615.
    PubMed     Abstract available


  16. NELLIGAN NM, Bender MR, Feltus FA
    Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning.
    BMC Cancer. 2022;22:612.
    PubMed     Abstract available


  17. LUO QW, Gao S, Lv X, Li SJ, et al
    A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:606.
    PubMed     Abstract available


    May 2022
  18. ZOU X, Zhou Q, Nie Y, Gou J, et al
    Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
    BMC Cancer. 2022;22:595.
    PubMed     Abstract available


  19. CAI Z, Tang B, Chen L, Lei W, et al
    Mast cell marker gene signature in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:577.
    PubMed     Abstract available


  20. MANN C, Berlth F, Hadzijusufovic E, Tagkalos E, et al
    Extended lower paratracheal lymph node resection during esophagectomy for cancer - safety and necessity.
    BMC Cancer. 2022;22:579.
    PubMed     Abstract available


  21. LIN C, Li M, Lin N, Zong J, et al
    RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:549.
    PubMed     Abstract available


  22. QIAN L, Ni T, Fei B, Sun H, et al
    An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
    BMC Cancer. 2022;22:545.
    PubMed     Abstract available


  23. HUO Z, Fu S, Ma C, Sheng S, et al
    Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:535.
    PubMed     Abstract available


  24. DOS SANTOS M, Lequesne J, Leconte A, Corbinais S, et al
    Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
    BMC Cancer. 2022;22:537.
    PubMed     Abstract available


  25. CAI M, Zheng Z, Bai Z, Ouyang K, et al
    Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
    BMC Cancer. 2022;22:530.
    PubMed     Abstract available


  26. LU XJD, Jackson E, Chew J, Nguyen S, et al
    Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers.
    BMC Cancer. 2022;22:513.
    PubMed     Abstract available


  27. JIN YN, Xia TL, Mai DM, Yao JJ, et al
    The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study.
    BMC Cancer. 2022;22:505.
    PubMed     Abstract available


  28. YANG Y, Zhu L, Cheng Y, Liu Z, et al
    Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study).
    BMC Cancer. 2022;22:506.
    PubMed     Abstract available


  29. QIU X, Wu H, Xu T, Xie S, et al
    Reflecting on the utility of standardized uptake values on (18)F-FDG PET in nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:495.
    PubMed     Abstract available


    April 2022
  30. REN L, Li P, Li Z, Chen Q, et al
    AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells.
    BMC Cancer. 2022;22:465.
    PubMed     Abstract available


  31. ZHANG Z, Zhang X, Yin Y, Zhao S, et al
    Integrating BRAF(V600E) mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.
    BMC Cancer. 2022;22:461.
    PubMed     Abstract available


  32. HERTEL M, Hagedorn L, Schmidt-Westhausen AM, Dommisch H, et al
    Comparison of five-year survival rates among patients with oral squamous cell carcinoma with and without association with syphilis: a retrospective case-control study.
    BMC Cancer. 2022;22:454.
    PubMed     Abstract available


  33. IIDA M, McDaniel NK, Kostecki KL, Welke NB, et al
    AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
    BMC Cancer. 2022;22:447.
    PubMed     Abstract available


  34. RUITER LN, van Dijk BAC, Bruggink AH, Doornaert PAH, et al
    Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands.
    BMC Cancer. 2022;22:444.
    PubMed     Abstract available


  35. DALHAMMAR K, Kristensson J, Falkenback D, Rasmussen BH, et al
    Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer - a comparative study of treatment strategy.
    BMC Cancer. 2022;22:434.
    PubMed     Abstract available


  36. LI PC, Huang RY, Yang YC, Hsieh KP, et al
    Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
    BMC Cancer. 2022;22:430.
    PubMed     Abstract available


  37. WANG Q, Wu Z, Zhan T, Fang S, et al
    Retraction Note: Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
    BMC Cancer. 2022;22:409.
    PubMed    


  38. NODA Y, Ishida M, Ueno Y, Fujisawa T, et al
    Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
    BMC Cancer. 2022;22:402.
    PubMed     Abstract available


  39. NIPP RD, Shulman E, Smith M, Brown PMC, et al
    Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer.
    BMC Cancer. 2022;22:383.
    PubMed     Abstract available


  40. KUBOTA K, Ito R, Narita N, Tanaka Y, et al
    Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
    BMC Cancer. 2022;22:368.
    PubMed     Abstract available


  41. ZHANG C, Li B, Zhang L, Chen F, et al
    Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
    BMC Cancer. 2022;22:354.
    PubMed     Abstract available


    March 2022
  42. LIU J, Lu J, Li W
    Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:352.
    PubMed     Abstract available


  43. LEE OH, Park YM, Ko SH, Lee K, et al
    Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study.
    BMC Cancer. 2022;22:345.
    PubMed     Abstract available


  44. ZHANG X, Zhang X, Jia Q, Li H, et al
    LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
    BMC Cancer. 2022;22:344.
    PubMed     Abstract available


  45. LIANG M, Xiao J, Chen M, Zheng B, et al
    Prognostic variables for conditional survival in patients with esophageal squamous cell carcinoma who underwent minimally invasive surgery.
    BMC Cancer. 2022;22:333.
    PubMed     Abstract available


  46. HUANG D, Li Y, Liu N, Zhang Z, et al
    Retraction Note: Identification of novel signaling components in N,N'-Dinitrosopiperazine-mediated metastasis of nasopharyngeal Carcinoma by quantitative phosphoproteomics.
    BMC Cancer. 2022;22:324.
    PubMed    


  47. YANG F, Sun Z, Wang D, Du T, et al
    MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    BMC Cancer. 2022;22:308.
    PubMed     Abstract available


  48. IKAWA T, Ishihara R, Matsueda K, Konishi K, et al
    Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
    BMC Cancer. 2022;22:301.
    PubMed     Abstract available


  49. WANG CP, Chen TC, Hsu WL, Hsiao JR, et al
    Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
    BMC Cancer. 2022;22:296.
    PubMed     Abstract available


  50. FENG J, Wang L, Wang L, Yang X, et al
    Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:284.
    PubMed     Abstract available


  51. BOSCOLO-RIZZO P, D'Alessandro A, Polesel J, Borsetto D, et al
    Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:243.
    PubMed     Abstract available


  52. PRUIJSSEN JT, Wenmakers A, Kessels RPC, Piai V, et al
    Long-term cognitive, psychosocial, and neurovascular complications of unilateral head and neck irradiation in young to middle-aged adults.
    BMC Cancer. 2022;22:244.
    PubMed     Abstract available


  53. CHENG J, Zhang R, Yan M, Li Y, et al
    Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:238.
    PubMed     Abstract available


  54. MIDORIKAWA S, Ohtsuru A
    Young people's perspectives of thyroid cancer screening and its harms after the nuclear accident in Fukushima Prefecture: a questionnaire survey indicating opt-out screening strategy of the thyroid examination as an ethical issue.
    BMC Cancer. 2022;22:235.
    PubMed     Abstract available


  55. KOSKINEN AI, Hemminki O, Forsti A, Hemminki K, et al
    Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century.
    BMC Cancer. 2022;22:227.
    PubMed     Abstract available


    February 2022
  56. WANG X, Hu B, Chen J, Xie F, et al
    Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site.
    BMC Cancer. 2022;22:207.
    PubMed     Abstract available


  57. YE L, Hu L, Liu W, Luo Y, et al
    Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    BMC Cancer. 2022;22:194.
    PubMed    


  58. FAN X, Huang Y, Xu P, Min Y, et al
    Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
    BMC Cancer. 2022;22:178.
    PubMed     Abstract available


  59. HSIEH CY, Lien MY, Lin CY, Lo WJ, et al
    Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.
    BMC Cancer. 2022;22:169.
    PubMed     Abstract available


  60. VEEN AV, Schiffmann LM, de Groot EM, Bartella I, et al
    The ISCON-trial protocol: laparoscopic ischemic conditioning prior to esophagectomy in patients with esophageal cancer and arterial calcifications.
    BMC Cancer. 2022;22:144.
    PubMed     Abstract available


    January 2022
  61. WU LL, Zhong JD, Zhu JL, Kang L, et al
    Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
    BMC Cancer. 2022;22:118.
    PubMed     Abstract available


  62. ZANG Z, Liu Y, Wang J, Liu Y, et al
    Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis.
    BMC Cancer. 2022;22:95.
    PubMed     Abstract available


  63. UENO T, Yatsuoka W, Ishiki H, Miyano K, et al
    Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
    BMC Cancer. 2022;22:90.
    PubMed     Abstract available


  64. BUCKLE GC, Mrema A, Mwachiro M, Ringo Y, et al
    Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
    BMC Cancer. 2022;22:82.
    PubMed     Abstract available


  65. GILLMAN A, Hayes M, Sheaf G, Walshe M, et al
    Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review.
    BMC Cancer. 2022;22:53.
    PubMed     Abstract available


  66. SCHLINTL V, Huemer F, Rinnerthaler G, Melchardt T, et al
    Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
    BMC Cancer. 2022;22:51.
    PubMed     Abstract available


  67. LIN C, Lin S, Zhu L, Lin S, et al
    Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
    BMC Cancer. 2022;22:35.
    PubMed     Abstract available


  68. ROSENBERG AJ, Izumchenko E, Pearson A, Gooi Z, et al
    Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
    BMC Cancer. 2022;22:17.
    PubMed     Abstract available


  69. HENNESSY MA, Hamid M, Keegan NM, Corrigan L, et al
    Metastatic gastroesophageal cancer in older patients - is this patient cohort represented in clinical trials?
    BMC Cancer. 2022;22:3.
    PubMed     Abstract available


    December 2021
  70. HUANG B, Chan EG, Pennathur A, Luketich JD, et al
    The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis.
    BMC Cancer. 2021;21:1334.
    PubMed     Abstract available


  71. XIAO L, Hu Q, Peng Y, Zheng K, et al
    TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of Cancer-associated fibroblasts.
    BMC Cancer. 2021;21:1329.
    PubMed     Abstract available


  72. OU D, Wu Y
    The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
    BMC Cancer. 2021;21:1327.
    PubMed     Abstract available


  73. LIU LT, Guo SS, Li H, Lin C, et al
    Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1320.
    PubMed     Abstract available


  74. WUSHOU A, Yibulayin F, Sheng L, Luo Y, et al
    Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database.
    BMC Cancer. 2021;21:1309.
    PubMed     Abstract available


  75. XU N, Lu M, Wang J, Li Y, et al
    Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway.
    BMC Cancer. 2021;21:1307.
    PubMed     Abstract available


  76. ZOUHRY Y, Taibi A, Durand-Fontanier S, Darbas T, et al
    Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
    BMC Cancer. 2021;21:1313.
    PubMed     Abstract available


  77. REN JL, Rojo RD, Perez JVD, Yeung SJ, et al
    Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors.
    BMC Cancer. 2021;21:1304.
    PubMed     Abstract available


  78. PU Y, Li Q, Wang Y, Xu L, et al
    pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
    BMC Cancer. 2021;21:1283.
    PubMed     Abstract available


    November 2021
  79. SUNDE B, Lindblad M, Malmstrom M, Hedberg J, et al
    Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
    BMC Cancer. 2021;21:1277.
    PubMed     Abstract available


  80. ZONG JF, Liang QD, Lu QJ, Liu YH, et al
    Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1274.
    PubMed     Abstract available


  81. YE L, Hu L, Liu W, Luo Y, et al
    Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    BMC Cancer. 2021;21:1250.
    PubMed     Abstract available


  82. ZHANG Y, Chen M, Liu Z, Wang X, et al
    The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma.
    BMC Cancer. 2021;21:1254.
    PubMed     Abstract available


  83. BALK M, Rupp R, Mantsopoulos K, Allner M, et al
    Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    BMC Cancer. 2021;21:1236.
    PubMed     Abstract available


  84. MCILVANNA E, Linden GJ, Craig SG, Lundy FT, et al
    Fusobacterium nucleatum and oral cancer: a critical review.
    BMC Cancer. 2021;21:1212.
    PubMed     Abstract available


  85. LI J, Yan T, Wu X, Ke X, et al
    Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    BMC Cancer. 2021;21:1205.
    PubMed     Abstract available


  86. ZHU X, Shanzhou Q, Li D, Pang X, et al
    PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis.
    BMC Cancer. 2021;21:1195.
    PubMed     Abstract available


  87. SHI K, Zhang JZ, Yang L, Li NN, et al
    Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:1196.
    PubMed     Abstract available


  88. NAGAKI Y, Motoyama S, Sato Y, Wakita A, et al
    Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
    BMC Cancer. 2021;21:1192.
    PubMed     Abstract available


  89. SUZUKI H, Sasaki E, Takano G, Goto S, et al
    Lymph node ratio as a predictor for minor salivary gland cancer in head and neck.
    BMC Cancer. 2021;21:1186.
    PubMed     Abstract available


  90. CHEN S, Lai H, Zhao J, Chen B, et al
    The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
    BMC Cancer. 2021;21:1183.
    PubMed     Abstract available


    October 2021
  91. ZHU Y, Yao W, Xu BC, Lei YY, et al
    Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
    BMC Cancer. 2021;21:1167.
    PubMed     Abstract available


  92. ROSVALL BR, Kostiuk M, Williams J, Matkin A, et al
    Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules.
    BMC Cancer. 2021;21:1142.
    PubMed     Abstract available


  93. CHEN Y, Huang Q, Chen J, Lin Y, et al
    Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.
    BMC Cancer. 2021;21:1130.
    PubMed     Abstract available


  94. KASSIR ZM, Li J, Harrison C, Johnson JT, et al
    Disparity of perception of quality of life between head and neck cancer patients and caregivers.
    BMC Cancer. 2021;21:1127.
    PubMed     Abstract available


  95. MERINO T, Pinto MP, Orellana MP, Martinez G, et al
    Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
    BMC Cancer. 2021;21:1114.
    PubMed     Abstract available


  96. MARTINO R, Fitch MI, Fuller CD, Hope A, et al
    The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
    BMC Cancer. 2021;21:1100.
    PubMed     Abstract available


  97. ZHANG QW, Wang JY, Qiao XF, Li TL, et al
    Variations in disease burden of laryngeal cancer attributable to alcohol use and smoking in 204 countries or territories, 1990-2019.
    BMC Cancer. 2021;21:1082.
    PubMed     Abstract available


  98. ZHOU Y, Zhang S, Min Z, Yu Z, et al
    Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    BMC Cancer. 2021;21:1085.
    PubMed     Abstract available


  99. MUHANNA N, Eu D, Chan HHL, Douglas C, et al
    Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
    BMC Cancer. 2021;21:1075.
    PubMed     Abstract available


  100. HUANG Q, Shen YJ, Hsueh CY, Guo Y, et al
    miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:1074.
    PubMed     Abstract available


    September 2021
  101. LV X, Han S, Xu B, Deng Y, et al
    The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:1072.
    PubMed     Abstract available


  102. AUGUSTE A, Joachim C, Deloumeaux J, Gaete S, et al
    Head and neck cancer risk factors in the French West Indies.
    BMC Cancer. 2021;21:1071.
    PubMed     Abstract available


  103. KAWASHITA Y, Kitamura M, Soutome S, Ukai T, et al
    Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study.
    BMC Cancer. 2021;21:1064.
    PubMed     Abstract available


  104. CHENG S, Yang L, Dai X, Wang J, et al
    The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
    BMC Cancer. 2021;21:1057.
    PubMed     Abstract available


  105. TAGKALOS E, van der Sluis PC, Berlth F, Poplawski A, et al
    Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial).
    BMC Cancer. 2021;21:1060.
    PubMed     Abstract available


  106. SHI C, Liu S, Tian X, Wang X, et al
    A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:1035.
    PubMed     Abstract available


  107. NIU C, Liu Y, Wang J, Liu Y, et al
    Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study.
    BMC Cancer. 2021;21:1034.
    PubMed     Abstract available


  108. TANIYAMA Y, Murakami K, Yoshida N, Takahashi K, et al
    Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study.
    BMC Cancer. 2021;21:1008.
    PubMed     Abstract available


  109. XIA T, Tian H, Zhang K, Zhang S, et al
    Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1003.
    PubMed     Abstract available


  110. WANG Y, Wang J, Chen Z, Ma M, et al
    Analysis of the correlation between high iodized salt intake and the risk of thyroid nodules: a large retrospective study.
    BMC Cancer. 2021;21:1000.
    PubMed     Abstract available


  111. LI R, Pang XF, Huang ZG, Yang LH, et al
    Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
    BMC Cancer. 2021;21:996.
    PubMed     Abstract available


  112. WANG ZY, Jiang YZ, Xiao W, Xue XB, et al
    Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
    BMC Cancer. 2021;21:988.
    PubMed     Abstract available


  113. ISHIZU T, Eichin D, Padzik A, Tuominen S, et al
    Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9.
    BMC Cancer. 2021;21:990.
    PubMed     Abstract available


  114. KHAIRAN P, Sobue T, Eshak ES, Zha L, et al
    Association of dietary intakes of vitamin B12, vitamin B6, folate, and methionine with the risk of esophageal cancer: the Japan Public Health Center-based (JPHC) prospective study.
    BMC Cancer. 2021;21:982.
    PubMed     Abstract available


  115. CHEN YH, Chen CH, Chien CY, Su YY, et al
    Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
    BMC Cancer. 2021;21:979.
    PubMed     Abstract available


    August 2021
  116. MINESAKI A, Kai K, Kuratomi Y, Aishima S, et al
    Infiltration of CD1a-positive dendritic cells in advanced laryngeal cancer correlates with unfavorable outcomes post-laryngectomy.
    BMC Cancer. 2021;21:973.
    PubMed     Abstract available


  117. MU G, Wang J, Liu Z, Zhang H, et al
    Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:960.
    PubMed     Abstract available


  118. LIU Z, Liu H, Dong Q, Li H, et al
    Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
    BMC Cancer. 2021;21:951.
    PubMed     Abstract available


  119. LI G, Xia YF, Huang YX, Okat D, et al
    Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
    BMC Cancer. 2021;21:944.
    PubMed     Abstract available


  120. FENG G, Xu Y, Ma N, Midorikawa K, et al
    Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:929.
    PubMed     Abstract available


  121. LI X, Liu Z, Zhou W, Liu X, et al
    Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
    BMC Cancer. 2021;21:922.
    PubMed     Abstract available


  122. LI MX, Sun XM, Cheng WG, Ruan HJ, et al
    Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:906.
    PubMed     Abstract available


  123. FUJIMA N, Andreu-Arasa VC, Meibom SK, Mercier GA, et al
    Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
    BMC Cancer. 2021;21:900.
    PubMed     Abstract available


  124. MASAKI C, Sugino K, Kobayashi S, Hosoi Y, et al
    Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients.
    BMC Cancer. 2021;21:894.
    PubMed     Abstract available


  125. ZAHID N, Zahid W, Khalid W, Azam I, et al
    Resilience and its associated factors in head and neck cancer patients in Pakistan: an analytical cross-sectional study.
    BMC Cancer. 2021;21:888.
    PubMed     Abstract available


    July 2021
  126. HE Y, Liu Z, Sheng S, Gao W, et al
    Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?
    BMC Cancer. 2021;21:878.
    PubMed     Abstract available


  127. ROUTILA J, Suvila K, Grenman R, Leivo I, et al
    Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:868.
    PubMed     Abstract available


  128. SINGH P, Bennett B, Bailey T, Taylor-Stokes G, et al
    Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.
    BMC Cancer. 2021;21:854.
    PubMed     Abstract available


  129. CHEN W, Luo YK, Zhang Y, Song Q, et al
    Ultrasound-guided implantation of radioactive (125)I seed in radioiodine refractory differentiated thyroid carcinoma.
    BMC Cancer. 2021;21:834.
    PubMed     Abstract available


  130. ZHU C, Gu L, Liu Z, Li J, et al
    Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:836.
    PubMed     Abstract available


  131. LI H, Zhang X, Yi C, He Y, et al
    Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    BMC Cancer. 2021;21:835.
    PubMed     Abstract available


  132. LANG K, Adeberg S, Harrabi S, Held T, et al
    Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
    BMC Cancer. 2021;21:812.
    PubMed     Abstract available


  133. STRAUB M, Sigman DM, Auderset A, Ollivier J, et al
    Distinct nitrogen isotopic compositions of healthy and cancerous tissue in mice brain and head&neck micro-biopsies.
    BMC Cancer. 2021;21:805.
    PubMed     Abstract available


  134. ZHOU YJ, Lu XF, Meng JL, Wang XY, et al
    Neo-adjuvant radiation therapy provides a survival advantage in T3-T4 nodal positive gastric and gastroesophageal junction adenocarcinoma: a SEER database analysis.
    BMC Cancer. 2021;21:771.
    PubMed     Abstract available


    June 2021
  135. HE G, Pang R, Han J, Jia J, et al
    TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.
    BMC Cancer. 2021;21:753.
    PubMed     Abstract available


  136. ITO T, Tsukahara K, Sato H, Shimizu A, et al
    Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
    BMC Cancer. 2021;21:742.
    PubMed     Abstract available


  137. MIYAWAKI Y, Sato H, Oya S, Sugita H, et al
    Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study.
    BMC Cancer. 2021;21:725.
    PubMed     Abstract available


  138. SANTERO M, Perez-Bracchiglione J, Acosta-Dighero R, Meade AG, et al
    Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews.
    BMC Cancer. 2021;21:712.
    PubMed     Abstract available


  139. BAKOS B, Kiss A, Arvai K, Szili B, et al
    Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
    BMC Cancer. 2021;21:706.
    PubMed     Abstract available


  140. SHI Y, Yang D, Qin Y
    Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
    BMC Cancer. 2021;21:705.
    PubMed     Abstract available


  141. UEHARA K, Tanabe Y, Hirota S, Higa S, et al
    Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
    BMC Cancer. 2021;21:688.
    PubMed     Abstract available


  142. FU JY, Zhang CP, Zhang ZY
    Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer.
    BMC Cancer. 2021;21:663.
    PubMed     Abstract available


  143. DRAGAN T, Duprez F, Van Gossum A, Gulyban A, et al
    Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
    BMC Cancer. 2021;21:656.
    PubMed     Abstract available


  144. HOXHAJ I, Vukovic V, Boccia S, Pastorino R, et al
    Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
    BMC Cancer. 2021;21:660.
    PubMed     Abstract available


  145. CHEN WJ, Xu WN, Wang HY, Chen XX, et al
    Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    BMC Cancer. 2021;21:651.
    PubMed     Abstract available


    May 2021
  146. LIU W, Yu B, Luo Y, Li J, et al
    Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    BMC Cancer. 2021;21:639.
    PubMed     Abstract available


  147. HEFT NEAL ME, Birkeland AC, Bhangale AD, Zhai J, et al
    Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
    BMC Cancer. 2021;21:636.
    PubMed     Abstract available


  148. LI X, Fang Q, Du W, Zhang X, et al
    Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:622.
    PubMed     Abstract available


  149. MUKHERJEE K, Sur D, Singh A, Rai S, et al
    Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
    BMC Cancer. 2021;21:628.
    PubMed     Abstract available


  150. FANG X, Wang S, Zhao J, Zhang Y, et al
    A population-based analysis of clinical features and lymph node dissection in head and neck malignant neurogenic tumors.
    BMC Cancer. 2021;21:598.
    PubMed     Abstract available


  151. CHEN Y, Hu N, Liao L, Yu K, et al
    ABO genotypes and the risk of esophageal and gastric cancers.
    BMC Cancer. 2021;21:589.
    PubMed     Abstract available


  152. O'CONNOR L, Smyth E, Bennett AE, Smith V, et al
    Identifying outcomes reported in exercise interventions in oesophagogastric cancer survivors: a systematic review.
    BMC Cancer. 2021;21:586.
    PubMed     Abstract available


  153. MAGHSOOMI Z, Emami Z, Malboosbaf R, Malek M, et al
    Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.
    BMC Cancer. 2021;21:579.
    PubMed     Abstract available


  154. QUINTANILHA JCF, Cursino MA, Borges JB, Torso NG, et al
    MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
    BMC Cancer. 2021;21:575.
    PubMed     Abstract available


  155. QIN M, Han F, Wu J, Gao FX, et al
    KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPbeta transcription.
    BMC Cancer. 2021;21:559.
    PubMed     Abstract available


  156. GURIZZAN C, Lorini L, Paderno A, Tomasoni M, et al
    Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
    BMC Cancer. 2021;21:561.
    PubMed     Abstract available


  157. MEI X, Yao X, Feng F, Cheng W, et al
    Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.
    BMC Cancer. 2021;21:543.
    PubMed     Abstract available


  158. BEYENE ET, Ketema SG, Alebachew AN, Saleh MY, et al
    Descriptive epidemiology of nasopharyngeal carcinoma at Tikur Anbessa Hospital, Ethiopia.
    BMC Cancer. 2021;21:540.
    PubMed     Abstract available


  159. YANG JH, Sun XS, Xiao BB, Liu LT, et al
    Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
    BMC Cancer. 2021;21:534.
    PubMed     Abstract available


  160. CHEN J, Xia YJ, Liu TY, Lai YH, et al
    Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    BMC Cancer. 2021;21:532.
    PubMed     Abstract available


  161. XU Y, Wu Z, Ye W, Xiao Y, et al
    Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:519.
    PubMed     Abstract available


  162. ARSA L, Siripoon T, Trachu N, Foyhirun S, et al
    Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    BMC Cancer. 2021;21:504.
    PubMed     Abstract available


    April 2021
  163. ALMANGUSH A, Alabi RO, Troiano G, Coletta RD, et al
    Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:480.
    PubMed     Abstract available


  164. ZHANG X, Song X, Lai Y, Zhu B, et al
    Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.
    BMC Cancer. 2021;21:483.
    PubMed     Abstract available


  165. KUNZ V, Wichmann G, Lehmann-Laue A, Mehnert-Theuerkauf A, et al
    Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study.
    BMC Cancer. 2021;21:478.
    PubMed     Abstract available


  166. JENSEN CB, Saucke MC, Pitt SC
    Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.
    BMC Cancer. 2021;21:471.
    PubMed     Abstract available


  167. WONG TJ, Li Q, Dodd V, Wang W, et al
    Oral cancer knowledge and screening behavior among smokers and non-smokers in rural communities.
    BMC Cancer. 2021;21:430.
    PubMed     Abstract available


  168. DUAN X, Shang X, Yue J, Ma Z, et al
    A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:431.
    PubMed     Abstract available


  169. ZHOU LQ, Hu Y, Xiao HJ
    The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:424.
    PubMed     Abstract available


  170. DING Y, Jiang R, Chen Y, Jing J, et al
    Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
    BMC Cancer. 2021;21:420.
    PubMed     Abstract available


  171. WEI M, Zhao L, Lv J, Li X, et al
    The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:415.
    PubMed     Abstract available


  172. BOGUSZEWICZ L, Bielen A, Jarczewski JD, Ciszek M, et al
    Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics.
    BMC Cancer. 2021;21:410.
    PubMed     Abstract available


  173. SAENTHAVEESUK P, Yang L, Zeng B, Xu M, et al
    Development and validation of multiparametric MRI-based nomogram for predicting occult metastasis risk in early tongue squamous cell carcinoma.
    BMC Cancer. 2021;21:408.
    PubMed     Abstract available


  174. WANG Y, Zhang X, Zhang X, Liu-Helmersson J, et al
    Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.
    BMC Cancer. 2021;21:403.
    PubMed     Abstract available


  175. ZHOU Z, Wu W, Li J, Liu C, et al
    Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:395.
    PubMed     Abstract available


  176. BERNADACH M, Lapeyre M, Dillies AF, Miroir J, et al
    Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
    BMC Cancer. 2021;21:360.
    PubMed     Abstract available


  177. NIE Z, Zhao P, Shang Y, Sun B, et al
    Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection.
    BMC Cancer. 2021;21:372.
    PubMed     Abstract available


  178. ZHU Q, Xu D
    Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
    BMC Cancer. 2021;21:344.
    PubMed     Abstract available


  179. ZHENG W, Chen C, Yu J, Jin C, et al
    An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
    BMC Cancer. 2021;21:345.
    PubMed     Abstract available


    March 2021
  180. YOSHIMURA S, Mori K, Ri M, Aikou S, et al
    Comparison of short-term outcomes between transthoracic and robot-assisted transmediastinal radical surgery for esophageal cancer: a prospective study.
    BMC Cancer. 2021;21:338.
    PubMed     Abstract available


  181. YANG X, Suo C, Zhang T, Yin X, et al
    A nomogram for screening esophageal squamous cell carcinoma based on environmental risk factors in a high-incidence area of China: a population-based case-control study.
    BMC Cancer. 2021;21:343.
    PubMed     Abstract available


  182. HE T, Yan RN, Chen HY, Zeng YY, et al
    Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.
    BMC Cancer. 2021;21:327.
    PubMed     Abstract available


  183. CHOI KH, Song JH, Park EY, Hong JH, et al
    Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
    BMC Cancer. 2021;21:317.
    PubMed     Abstract available


  184. PHAM DX, Nguyen HD, Phung AHT, Bui TD, et al
    Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996-2015): a population-based study.
    BMC Cancer. 2021;21:296.
    PubMed     Abstract available


  185. LIU Z, Cheng C, Luo X, Xia Q, et al
    Retraction Note: CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:273.
    PubMed    


  186. LI C, Tao C, Bai T, Li Z, et al
    Beam complexity and monitor unit efficiency comparison in two different volumetric modulated arc therapy delivery systems using automated planning.
    BMC Cancer. 2021;21:261.
    PubMed     Abstract available


  187. CHOI CK, Yang J, Kweon SS, Cho SH, et al
    Association between ALDH2 polymorphism and esophageal cancer risk in South Koreans: a case-control study.
    BMC Cancer. 2021;21:254.
    PubMed     Abstract available


  188. WANG Y, Wang M, Tang Y, Sun B, et al
    Perioperative mortality of head and neck cancers.
    BMC Cancer. 2021;21:256.
    PubMed     Abstract available


  189. ZHANG S, Zhang R, Wang C, Gong W, et al
    Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth.
    BMC Cancer. 2021;21:225.
    PubMed     Abstract available


  190. ZOU Y, Zhang H, Li W, Guo Y, et al
    Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.
    BMC Cancer. 2021;21:221.
    PubMed     Abstract available


    February 2021
  191. CHIAMULERA MMA, Zancan CB, Remor AP, Cordeiro MF, et al
    Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:205.
    PubMed     Abstract available


  192. CHOI SY, Lee E, Kim E, Chung MK, et al
    Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
    BMC Cancer. 2021;21:178.
    PubMed     Abstract available


  193. ABDEL HAMID HM, Darwish ZE, Elsheikh SM, Mourad GM, et al
    Following cytotoxic nanoconjugates from injection to halting the cell cycle machinery and its therapeutic implications in oral cancer.
    BMC Cancer. 2021;21:170.
    PubMed     Abstract available


  194. CHEN D, Wang W, Mo J, Ren Q, et al
    Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
    BMC Cancer. 2021;21:145.
    PubMed     Abstract available


  195. WENTER V, Albert NL, Ahmaddy F, Unterrainer M, et al
    The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study.
    BMC Cancer. 2021;21:139.
    PubMed     Abstract available


  196. LIANG YJ, Mei XY, Zeng B, Zhang SE, et al
    Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.
    BMC Cancer. 2021;21:122.
    PubMed     Abstract available


  197. ZHANG Z, Chen C, Fang Y, Li S, et al
    Development of a prognostic signature for esophageal cancer based on nine immune related genes.
    BMC Cancer. 2021;21:113.
    PubMed     Abstract available


  198. WANG X, Wang H, Wang H, Huang J, et al
    Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.
    BMC Cancer. 2021;21:111.
    PubMed     Abstract available


    January 2021
  199. HAMMERMULLER C, Hinz A, Dietz A, Wichmann G, et al
    Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population.
    BMC Cancer. 2021;21:94.
    PubMed     Abstract available


  200. KONDO S, Hirakawa H, Ikegami T, Uehara T, et al
    Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2021;21:87.
    PubMed     Abstract available


  201. SOLIS-PAZMINO P, Salazar-Vega J, Lincango-Naranjo E, Garcia C, et al
    Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    BMC Cancer. 2021;21:42.
    PubMed     Abstract available


  202. ZHAO F, Lu RX, Liu JY, Fan J, et al
    Development and validation of nomograms to intraoperatively predict metastatic patterns in regional lymph nodes in patients diagnosed with esophageal cancer.
    BMC Cancer. 2021;21:22.
    PubMed     Abstract available


    December 2020
  203. MUKHOPADHYAY S, Ghosh S, Das D, Arun P, et al
    Application of Random Forest and data integration identifies three dysregulated genes and enrichment of Central Carbon Metabolism pathway in Oral Cancer.
    BMC Cancer. 2020;20:1219.
    PubMed     Abstract available


  204. KATAGIRI T, Ohyama Y, Miyamoto H, Egawa Y, et al
    Pathological responses to low-dose irradiation and Pepleomycin in Oral squamous cell carcinoma are predictive of Locoregional control.
    BMC Cancer. 2020;20:1216.
    PubMed     Abstract available


  205. ZHANG J, Li H, Zhou L, Yu L, et al
    Modified nodal stage of esophageal cancer based on the evaluation of the hazard rate of the negative and positive lymph node.
    BMC Cancer. 2020;20:1200.
    PubMed     Abstract available


  206. DATAR S, Cabanillas M, Dadu R, Ost D, et al
    Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents.
    BMC Cancer. 2020;20:1181.
    PubMed     Abstract available


  207. HO SY, Tsang RKY
    Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas.
    BMC Cancer. 2020;20:1172.
    PubMed     Abstract available


    November 2020
  208. KALISZEWSKI K, Diakowska D, Nowak L, Wojtczak B, et al
    The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
    BMC Cancer. 2020;20:1166.
    PubMed     Abstract available


  209. XIE Z, Li X, He Y, Wu S, et al
    Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
    BMC Cancer. 2020;20:1143.
    PubMed     Abstract available


  210. ZHU K, Lin R, Zhang Z, Chen H, et al
    Impact of prior cancer history on the survival of patients with larynx cancer.
    BMC Cancer. 2020;20:1137.
    PubMed     Abstract available


  211. KAGAMI T, Yamade M, Suzuki T, Uotani T, et al
    The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy.
    BMC Cancer. 2020;20:1123.
    PubMed     Abstract available


  212. KANG HY, Kim I, Kim YY, Bahk J, et al
    Income differences in screening, incidence, postoperative complications, and mortality of thyroid cancer in South Korea: a national population-based time trend study.
    BMC Cancer. 2020;20:1096.
    PubMed     Abstract available


  213. TONG Y, Hu C, Huang Z, Fan Z, et al
    Novel nomogram to predict risk of bone metastasis in newly diagnosed thyroid carcinoma: a population-based study.
    BMC Cancer. 2020;20:1055.
    PubMed     Abstract available


    October 2020
  214. GU B, Fang Q, Wu Y, Du W, et al
    Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival.
    BMC Cancer. 2020;20:1034.
    PubMed     Abstract available


  215. ZHANG F, Liu Y, Yang Y, Yang K, et al
    Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    BMC Cancer. 2020;20:1015.
    PubMed     Abstract available


  216. HOSHINO I, Nabeya Y, Takiguchi N, Gunji H, et al
    Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
    BMC Cancer. 2020;20:1007.
    PubMed     Abstract available


  217. YANG J, Shang J, Song Q, Yang Z, et al
    ECCDIA: an interactive web tool for the comprehensive analysis of clinical and survival data of esophageal cancer patients.
    BMC Cancer. 2020;20:985.
    PubMed     Abstract available


  218. AN YZ, Cho E, Ling J, Zhang X, et al
    The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.
    BMC Cancer. 2020;20:987.
    PubMed     Abstract available


  219. ZHAO S, Qi W, Chen J
    Role of a multidisciplinary team in administering radiotherapy for esophageal cancer.
    BMC Cancer. 2020;20:974.
    PubMed     Abstract available


  220. ZHU L, Dong L, Feng M, Yang F, et al
    Profiles of autophagy-related genes in esophageal adenocarcinoma.
    BMC Cancer. 2020;20:943.
    PubMed     Abstract available


    September 2020
  221. HECHT M, Hahn D, Wolber P, Hautmann MG, et al
    Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer.
    BMC Cancer. 2020;20:933.
    PubMed     Abstract available


  222. FAN C, Wang J, Tang Y, Zhang S, et al
    Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers.
    BMC Cancer. 2020;20:917.
    PubMed     Abstract available


  223. ELHALAWANI H, Mohamed ASR, Elgohari B, Lin TA, et al
    Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:912.
    PubMed     Abstract available


  224. GAO LR, Wang X, Han W, Deng W, et al
    A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
    BMC Cancer. 2020;20:901.
    PubMed     Abstract available


  225. IZKHAKOV E, Keinan-Boker L, Barchana M, Shacham Y, et al
    Long-term all-cause mortality and its association with cardiovascular risk factors in thyroid cancer survivors: an Israeli population-based study.
    BMC Cancer. 2020;20:892.
    PubMed     Abstract available


  226. LORENZEN S, Biederstadt A, Ronellenfitsch U, Reissfelder C, et al
    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
    BMC Cancer. 2020;20:886.
    PubMed     Abstract available


  227. CHANG X, Deng L, Ni W, Li C, et al
    Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
    BMC Cancer. 2020;20:877.
    PubMed     Abstract available


  228. YOON JY, Brezden-Masley C, Streutker CJ
    Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
    BMC Cancer. 2020;20:860.
    PubMed     Abstract available


  229. ALMANGUSH A, Makitie AA, Hagstrom J, Haglund C, et al
    Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
    BMC Cancer. 2020;20:843.
    PubMed     Abstract available


  230. ZHANG Y, Wang J, Dai N, Han P, et al
    Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach.
    BMC Cancer. 2020;20:835.
    PubMed     Abstract available


  231. HSIEH CY, Lein MY, Yang SN, Wang YC, et al
    Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study.
    BMC Cancer. 2020;20:832.
    PubMed     Abstract available


    August 2020
  232. LEE YG, Kang EJ, Keam B, Choi JH, et al
    Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
    BMC Cancer. 2020;20:813.
    PubMed     Abstract available


  233. ZHANG B, Gao S, Li R, Li Y, et al
    Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    BMC Cancer. 2020;20:815.
    PubMed     Abstract available


  234. TU XP, Li H, Chen LS, Luo XN, et al
    OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:794.
    PubMed     Abstract available


  235. ZENG H, Song X, Ji J, Chen L, et al
    HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
    BMC Cancer. 2020;20:796.
    PubMed     Abstract available


  236. CHEN C, Chen S, Cao H, Wang J, et al
    Prognostic significance of autophagy-related genes within esophageal carcinoma.
    BMC Cancer. 2020;20:797.
    PubMed     Abstract available


  237. ZHAO J, Wen J, Wang S, Yao J, et al
    Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies.
    BMC Cancer. 2020;20:788.
    PubMed     Abstract available


  238. ZARGARI S, Negahban Khameneh S, Rad A, Forghanifard MM, et al
    MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:789.
    PubMed     Abstract available


  239. LEERS JM, Knepper L, van der Veen A, Schroder W, et al
    The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    BMC Cancer. 2020;20:781.
    PubMed     Abstract available


  240. CIAPPUCCINI R, Heutte N, Lasne-Cardon A, Saguet-Rysanek V, et al
    Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.
    BMC Cancer. 2020;20:765.
    PubMed     Abstract available


  241. WEI H, Yu K, Liu Y, Li L, et al
    Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    BMC Cancer. 2020;20:756.
    PubMed     Abstract available


  242. SHADMANI FK, Farzadfar F, Yoosefi M, Mansori K, et al
    Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001-2030.
    BMC Cancer. 2020;20:752.
    PubMed     Abstract available


  243. JAMIESON L, Forster MD, Zaki K, Mithra S, et al
    Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study.
    BMC Cancer. 2020;20:743.
    PubMed     Abstract available


  244. YANG Y, Li L, Zheng Y, Liu Q, et al
    A prospective, single-arm, phase II clinical trial of intraoperative radiotherapy using a low-energy X-ray source for local advanced Laryngocarcinoma (ILAL): a study protocol.
    BMC Cancer. 2020;20:734.
    PubMed     Abstract available


  245. KIM H, Kwon M, Kim B, Jung HA, et al
    Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
    BMC Cancer. 2020;20:727.
    PubMed     Abstract available


  246. WANG J, Tian S, Sun J, Zhang J, et al
    The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:731.
    PubMed     Abstract available


  247. BIAU J, Thivat E, Millardet C, Saroul N, et al
    A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
    BMC Cancer. 2020;20:730.
    PubMed     Abstract available


    July 2020
  248. BUSSMANN L, Laban S, Wittekindt C, Stromberger C, et al
    Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
    BMC Cancer. 2020;20:701.
    PubMed     Abstract available


  249. BAGHEL SS, Singhal P, Verma N, Sehra R, et al
    Is thyroid excision mandatory with laryngectomy in carcinoma larynx?
    BMC Cancer. 2020;20:700.
    PubMed     Abstract available


  250. JIANG C, Gao H, Zhang L, Li H, et al
    Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    BMC Cancer. 2020;20:667.
    PubMed     Abstract available


  251. LIN JL, Lin JX, Zheng CH, Li P, et al
    Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    BMC Cancer. 2020;20:638.
    PubMed     Abstract available


  252. LOPEZ GAVILANEZ E, Bautista Litardo N, Navarro Chavez M, Hernandez Bonilla M, et al
    Thyroid cancer in Ecuador.
    BMC Cancer. 2020;20:637.
    PubMed     Abstract available


  253. JIANG X, Huang Z, Sun X, Zheng X, et al
    CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    BMC Cancer. 2020;20:632.
    PubMed     Abstract available


  254. YIBULAYIN F, Feng L, Wang M, Lu MM, et al
    Head & neck acinar cell carcinoma: a population-based study using the seer registry.
    BMC Cancer. 2020;20:631.
    PubMed     Abstract available


    June 2020
  255. FENG Y, Yan S, Huang Y, Huang Q, et al
    High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:602.
    PubMed     Abstract available


  256. BISSEY PA, Teng M, Law JH, Shi W, et al
    MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    BMC Cancer. 2020;20:597.
    PubMed     Abstract available


  257. LI G, Qiu B, Huang YX, Doyen J, et al
    Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
    BMC Cancer. 2020;20:599.
    PubMed     Abstract available


  258. WANG Q, Wu Z, Zhan T, Fang S, et al
    Correction to: Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
    BMC Cancer. 2020;20:593.
    PubMed     Abstract available


  259. LI Y, Wu G, Yang W, Wang X, et al
    Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:581.
    PubMed     Abstract available


  260. HASEGAWA T, Iga T, Takeda D, Amano R, et al
    Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study.
    BMC Cancer. 2020;20:568.
    PubMed     Abstract available


  261. MORRISSEY ME, Byrne R, Nulty C, McCabe NH, et al
    The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation.
    BMC Cancer. 2020;20:566.
    PubMed     Abstract available


  262. VARDARLI I, Weidemann F, Aboukoura M, Herrmann K, et al
    Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis.
    BMC Cancer. 2020;20:550.
    PubMed     Abstract available


  263. WANG C, Zhao K, Hu S, Huang Y, et al
    A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR.
    BMC Cancer. 2020;20:544.
    PubMed     Abstract available


  264. CHEN PJ, Yap WK, Chang YC, Tseng CK, et al
    Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer.
    BMC Cancer. 2020;20:545.
    PubMed     Abstract available


  265. RICHARDS HS, Blazeby JM, Portal A, Harding R, et al
    A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.
    BMC Cancer. 2020;20:543.
    PubMed     Abstract available


  266. FANG Q, Gao H, Gao Q, Sun J, et al
    Elective neck dissection versus wait-and-see policy in cT1N0 buccal squamous cell carcinoma.
    BMC Cancer. 2020;20:537.
    PubMed     Abstract available


  267. KLEIN NULENT TJW, Valstar MH, Smit LA, Smeele LE, et al
    Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck.
    BMC Cancer. 2020;20:519.
    PubMed     Abstract available


  268. NGAMPHAIBOON N, Dechaphunkul A, Setakornnukul J, Dechaphunkul T, et al
    Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand.
    BMC Cancer. 2020;20:518.
    PubMed     Abstract available


  269. SHAH R, Sharma V, Bhat A, Singh H, et al
    MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India.
    BMC Cancer. 2020;20:497.
    PubMed     Abstract available


  270. ZHANG B, Lian Z, Zhong L, Zhang X, et al
    Machine-learning based MRI radiomics models for early detection of radiation-induced brain injury in nasopharyngeal carcinoma.
    BMC Cancer. 2020;20:502.
    PubMed     Abstract available


  271. HUMPHRIES MP, Craig SG, Kacprzyk R, Fisher NC, et al
    The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.
    BMC Cancer. 2020;20:500.
    PubMed     Abstract available


  272. FAHEY PP, Page A, Stone G, Astell-Burt T, et al
    Augmenting cancer registry data with health survey data with no cases in common: the relationship between pre-diagnosis health behaviour and post-diagnosis survival in oesophageal cancer.
    BMC Cancer. 2020;20:496.
    PubMed     Abstract available


  273. TINTELNOT J, Goekkurt E, Binder M, Thuss-Patience P, et al
    Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
    BMC Cancer. 2020;20:503.
    PubMed     Abstract available


    May 2020
  274. SARASWAT N, Pillay R, Everett B, George A, et al
    Knowledge, attitudes and practices of South Asian immigrants in developed countries regarding oral cancer: an integrative review.
    BMC Cancer. 2020;20:477.
    PubMed     Abstract available


  275. O'NEILL L, Guinan E, Doyle S, Connolly D, et al
    Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial.
    BMC Cancer. 2020;20:415.
    PubMed     Abstract available


  276. ZHOU X, Zheng Z, Chen C, Zhao B, et al
    Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study.
    BMC Cancer. 2020;20:407.
    PubMed     Abstract available


  277. HOESSEINI A, Dronkers EAC, Sewnaik A, Hardillo JAU, et al
    Head and neck cancer patients' preferences for individualized prognostic information: a focus group study.
    BMC Cancer. 2020;20:399.
    PubMed     Abstract available


  278. WANG BC, Xiao BY, Lin GH, Wang C, et al
    The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:393.
    PubMed     Abstract available


  279. YANG H, Su H, Hu N, Wang C, et al
    Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
    BMC Cancer. 2020;20:388.
    PubMed     Abstract available


  280. HU W, Li H, Wang S
    LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
    BMC Cancer. 2020;20:376.
    PubMed     Abstract available


  281. CHEN Q, Li J, Yang X, Ma J, et al
    Prdx1 promotes the loss of primary cilia in esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:372.
    PubMed     Abstract available


  282. TRAN TV, Dang KX, Pham QH, Nguyen UD, et al
    Evaluation of the expression levels of BRAF(V600E) mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay.
    BMC Cancer. 2020;20:368.
    PubMed     Abstract available


    April 2020
  283. GOVENDER R, Smith CH, Barratt H, Gardner B, et al
    SIP SMART: a parallel group randomised feasibility trial of a tailored pre-treatment swallowing intervention package compared with usual care for patients with head and neck cancer.
    BMC Cancer. 2020;20:360.
    PubMed     Abstract available


  284. BANDO H, Kotani D, Tsushima T, Hara H, et al
    TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:336.
    PubMed     Abstract available


  285. KIM EK, Cho YA, Koh YW, Shin HA, et al
    Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:348.
    PubMed     Abstract available


  286. KANG HN, Kim JH, Park AY, Choi JW, et al
    Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
    BMC Cancer. 2020;20:316.
    PubMed     Abstract available


  287. CHAN MY, Lee BJ, Chang PS, Hsiao HY, et al
    The risks of ubiquinone and beta-carotene deficiency and metabolic disorders in patients with oral cancer.
    BMC Cancer. 2020;20:310.
    PubMed     Abstract available


  288. SUN HB, Xing WQ, Liu XB, Zheng Y, et al
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903).
    BMC Cancer. 2020;20:303.
    PubMed     Abstract available


  289. SHEILL G, Guinan E, O'Neill L, Normand C, et al
    Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PRE-HIIT): protocol for a randomized controlled trial.
    BMC Cancer. 2020;20:321.
    PubMed     Abstract available


  290. BROWN J, Stepien AJ, Willem P
    Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa.
    BMC Cancer. 2020;20:281.
    PubMed     Abstract available


  291. SUN LP, Yan LB, Liu ZZ, Zhao WJ, et al
    Dietary factors and risk of mortality among patients with esophageal cancer: a systematic review.
    BMC Cancer. 2020;20:287.
    PubMed     Abstract available


  292. WANG D, Yu S, Zhai L, Xu J, et al
    Patterns of regional lymph node failure of locally advanced hypopharyngeal squamous cell carcinoma after first-line treatment with surgery and/or intensity-modulated radiotherapy.
    BMC Cancer. 2020;20:283.
    PubMed     Abstract available


    March 2020
  293. ZHANG J, Lin H, Jiang H, Jiang H, et al
    A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma.
    BMC Cancer. 2020;20:266.
    PubMed     Abstract available


  294. KAWAUCHI K, Furuya S, Hirata K, Katoh C, et al
    A convolutional neural network-based system to classify patients using FDG PET/CT examinations.
    BMC Cancer. 2020;20:227.
    PubMed     Abstract available


  295. XIONG Y, Neskey DM, Horton JD, Paulos CM, et al
    Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma.
    BMC Cancer. 2020;20:229.
    PubMed     Abstract available


  296. SRISUTTEE R, Arayataweegool A, Mahattanasakul P, Tangjaturonrasme N, et al
    Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma.
    BMC Cancer. 2020;20:218.
    PubMed     Abstract available


  297. WU D, Hu S, Hou Y, He Y, et al
    Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
    BMC Cancer. 2020;20:199.
    PubMed     Abstract available


  298. YANG J, Lu Z, Li L, Li Y, et al
    Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis.
    BMC Cancer. 2020;20:176.
    PubMed     Abstract available


    February 2020
  299. FEHR M, Hawle H, Hayoz S, Thuss-Patience P, et al
    High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
    BMC Cancer. 2020;20:166.
    PubMed     Abstract available


  300. KINGMA BF, Eshuis WJ, de Groot EM, Feenstra ML, et al
    Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: a randomized controlled multicenter trial (PEPMEN trial).
    BMC Cancer. 2020;20:142.
    PubMed     Abstract available


  301. NICHOLS AC, Lang P, Prisman E, Berthelet E, et al
    Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
    BMC Cancer. 2020;20:125.
    PubMed     Abstract available


  302. YOO MH, Kim HJ, Choi IH, Park S, et al
    Shear wave elasticity by tracing total nodule showed high reproducibility and concordance with fibrosis in thyroid cancer.
    BMC Cancer. 2020;20:118.
    PubMed     Abstract available


  303. LIU D, Jian X, Xu P, Zhu R, et al
    Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis.
    BMC Cancer. 2020;20:107.
    PubMed     Abstract available


    January 2020
  304. WANG C, Wei H, Li Y
    Comparison of fully-covered vs partially covered self-expanding metallic stents for palliative treatment of inoperable esophageal malignancy: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:73.
    PubMed     Abstract available


  305. YAMAMOTO K, Ohnishi S, Mizushima T, Kodaira J, et al
    Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV.
    BMC Cancer. 2020;20:64.
    PubMed     Abstract available


  306. CHEN M, Liu X, Han C, Wang X, et al
    Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).
    BMC Cancer. 2020;20:36.
    PubMed     Abstract available


  307. YUAN S, Lin LS, Gan RH, Huang L, et al
    Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
    BMC Cancer. 2020;20:33.
    PubMed     Abstract available


  308. SCHALLENBERG S, Bork J, Essakly A, Alakus H, et al
    Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    BMC Cancer. 2020;20:12.
    PubMed     Abstract available


  309. MELO-HANCHUK TD, Martins MB, Cunha LL, Soares FA, et al
    Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.
    BMC Cancer. 2020;20:23.
    PubMed     Abstract available


    December 2019
  310. SUH HY, Choi H, Paeng JC, Cheon GJ, et al
    Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer.
    BMC Cancer. 2019;19:1260.
    PubMed     Abstract available


  311. FLEEMAN N, Houten R, Chaplin M, Beale S, et al
    A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine.
    BMC Cancer. 2019;19:1209.
    PubMed     Abstract available


    November 2019
  312. CORDES M, Gotz TI, Horstrup K, Kuwert T, et al
    Growth rates of malignant and benign thyroid nodules in an ultrasound follow-up study: a retrospective cohort study.
    BMC Cancer. 2019;19:1139.
    PubMed     Abstract available


  313. NOPMANEEPAISARN T, Tangjaturonrasme N, Rawangban W, Vinayanuwattikun C, et al
    Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    BMC Cancer. 2019;19:1050.
    PubMed     Abstract available


    October 2019
  314. LIU P, McMenamin UC, Spence AD, Johnston BT, et al
    Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
    BMC Cancer. 2019;19:1017.
    PubMed     Abstract available


  315. TITOV SE, Ivanov MK, Demenkov PS, Katanyan GA, et al
    Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.
    BMC Cancer. 2019;19:1010.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: